
Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals
Join our daily newsletter At The Bell to receive exclusive market insights With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks in the sector with room to run. Recent moves from …